THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 96 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242 | -16.6% | 144 | 0.0% | 0.00% | – |
| Q2 2023 | $1,490 | -4.6% | 144 | 0.0% | 0.00% | – |
| Q1 2023 | $1,562 | -3.3% | 144 | 0.0% | 0.00% | – |
| Q4 2022 | $1,616 | -19.2% | 144 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 144 | +63.6% | 0.00% | – |
| Q4 2021 | $0 | – | 88 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 88 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 88 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 88 | +57.1% | 0.00% | – |
| Q4 2020 | $0 | – | 56 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 56 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 56 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -50.0% | 56 | -64.1% | 0.00% | – |
| Q2 2018 | $4,000 | +100.0% | 156 | +178.6% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 56 | +55.6% | 0.00% | – |
| Q4 2017 | $2,000 | -99.0% | 36 | -99.4% | 0.00% | – |
| Q3 2016 | $210,000 | +54.4% | 5,800 | -3.2% | 0.00% | – |
| Q2 2016 | $136,000 | +23.6% | 5,992 | +3.3% | 0.00% | – |
| Q1 2016 | $110,000 | +14.6% | 5,800 | 0.0% | 0.00% | – |
| Q4 2015 | $96,000 | +50.0% | 5,800 | 0.0% | 0.00% | – |
| Q3 2015 | $64,000 | -15.8% | 5,800 | 0.0% | 0.00% | – |
| Q2 2015 | $76,000 | -24.0% | 5,800 | -0.3% | 0.00% | – |
| Q1 2015 | $100,000 | +16.3% | 5,815 | +0.3% | 0.00% | – |
| Q4 2014 | $86,000 | -68.1% | 5,800 | -50.4% | 0.00% | – |
| Q3 2014 | $270,000 | +2600.0% | 11,684 | +4014.1% | 0.00% | – |
| Q2 2014 | $10,000 | – | 284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |